메뉴 건너뛰기




Volumn 22, Issue 4, 2004, Pages 750-

Dose density by any other name

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

EID: 85047697743     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2004.99.130     Document Type: Letter
Times cited : (6)

References (8)
  • 1
    • 0037687355 scopus 로고    scopus 로고
    • Randomized trial of dose-dense vs conventionally scheduled and sequential vs. Concurrent combination chemotherapy as postoperative adjuvant treatment of nose-positive primary breast cancer: First report of Intergroup trial C9741/Cancer and Acute Leukemia Group B Trial 9741
    • Citron ML, Berry DA, Cirricione C, et al: Randomized trial of dose-dense vs conventionally scheduled and sequential vs. concurrent combination chemotherapy as postoperative adjuvant treatment of nose-positive primary breast cancer: First report of Intergroup trial C9741/Cancer and Acute Leukemia Group B Trial 9741. J Clin Oncol 21:1431-1439, 2003
    • (2003) J Clin Oncol , vol.21 , pp. 1431-1439
    • Citron, M.L.1    Berry, D.A.2    Cirricione, C.3
  • 2
    • 0017694856 scopus 로고
    • Radiotherapy in Burkitt's lymphoma: Conventional or superfractionated regimen: Early results
    • Norin T, Onyango J: Radiotherapy in Burkitt's lymphoma: Conventional or superfractionated regimen: Early results. Int J Radiat Oncol Biol Phys 2:399, 1977
    • (1977) Int J Radiat Oncol Biol Phys , vol.2 , pp. 399
    • Norin, T.1    Onyango, J.2
  • 3
    • 0019222915 scopus 로고
    • Measurement of drug dosage intensity in MVPP therapy in Hodgkin's disease
    • Grean JA, Dawson AA, Fell LF, et al: Measurement of drug dosage intensity in MVPP therapy in Hodgkin's disease. Br J Clin Pharmacol 9:511-514, 1980
    • (1980) Br J Clin Pharmacol , vol.9 , pp. 511-514
    • Grean, J.A.1    Dawson, A.A.2    Fell, L.F.3
  • 4
    • 0021744793 scopus 로고
    • The importance of dose intensity in chemotherapy of metastatic breast cancer
    • Hryniuk W, Bush H: The importance of dose intensity in chemotherapy of metastatic breast cancer. J Clin Oncol 2:1281-1287, 1984
    • (1984) J Clin Oncol , vol.2 , pp. 1281-1287
    • Hryniuk, W.1    Bush, H.2
  • 5
    • 0022921982 scopus 로고
    • Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer
    • Hryniuk W, Levine MN: Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer. J Clin Oncol 4:1162-1170, 1986
    • (1986) J Clin Oncol , vol.4 , pp. 1162-1170
    • Hryniuk, W.1    Levine, M.N.2
  • 6
    • 0020539440 scopus 로고
    • Accelerated fractionation vs hyperfractionation: Rationale for several treatments per day
    • Thames HA, Peters LJ, Withers HR: Accelerated fractionation vs hyperfractionation: rationale for several treatments per day. Int J Radiat Oncol Biol Phys 9:127, 1983
    • (1983) Int J Radiat Oncol Biol Phys , vol.9 , pp. 127
    • Thames, H.A.1    Peters, L.J.2    Withers, H.R.3
  • 7
    • 0031720392 scopus 로고    scopus 로고
    • A single scale for comparing dose intensity of all chemotherapy regimens in breast cancer: Summation dose intensity
    • Hryniuk W, Frei E, Wright FA: A single scale for comparing dose intensity of all chemotherapy regimens in breast cancer: Summation dose intensity. J Clin Oncol 16:3137-3147, 1998
    • (1998) J Clin Oncol , vol.16 , pp. 3137-3147
    • Hryniuk, W.1    Frei, E.2    Wright, F.A.3
  • 8
    • 0002791865 scopus 로고
    • Introduction of cumulative dose intensity product (DIP) for measuring the delivered dose intensity of chemotherapy: Analysis of the British Columbia breast cancer randomized study
    • Ng V, Ragaz J, Spinelli J, et al: Introduction of cumulative dose intensity product (DIP) for measuring the delivered dose intensity of chemotherapy: Analysis of the British Columbia breast cancer randomized study. Proc Am Soc Clin Oncol 8:47, 1989
    • (1989) Proc Am Soc Clin Oncol , vol.8 , pp. 47
    • Ng, V.1    Ragaz, J.2    Spinelli, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.